![Steve Krognes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steve Krognes
Directeur/Membre du Conseil chez
DENALI THERAPEUTICS INC.
Fortune : 20 M $ au 31/05/2026
Profil
M. Steve E. Krognes est un administrateur indépendant de Gritstone Oncology, Inc., un administrateur indépendant de RLS Global AB, un administrateur indépendant de Corvus Pharmaceuticals, Inc. et un trésorier, directeur financier et comptable de Denali Therapeutics, Inc. Il siège au conseil d'administration de Gritstone Oncology, Inc, de RLS Global AB et de Corvus Pharmaceuticals, Inc. Auparavant, M. Krognes a occupé les postes de directeur financier, de vice-président senior et de responsable régional des finances et des technologies de l'information chez Genentech, Inc. et de président de la Genentech Access To Care Foundation, ainsi que ceux de responsable des fusions et acquisitions chez Roche Holding AG et de directeur des fusions et acquisitions chez GiroBank A/S. Il a également siégé au conseil d'administration de la California Academy of Sciences et de la California Life Sciences Association. Il a obtenu son diplôme de premier cycle à la Wharton School de l'université de Pennsylvanie et un MBA à la Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DENALI THERAPEUTICS INC. 0,52 % | 03/06/2026 | 819 999 ( 0,52 % ) | 17 M $ | 31/05/2026 |
GUARDANT HEALTH, INC. 0,01 % | 17/06/2026 | 14 425 ( 0,01 % ) | 2 M $ | 31/05/2026 |
ARGENX SE 0 % | 03/04/2026 | 1 459 ( 0 % ) | 1 M $ | 31/05/2026 |
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Steve Krognes
| Sociétés | Poste | Début |
|---|---|---|
| DENALI THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/05/2022 |
| GUARDANT HEALTH, INC. | Directeur/Membre du Conseil | 30/06/2022 |
| ARGENX SE | Directeur/Membre du Conseil | 27/02/2023 |
| PLIANT THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/06/2024 |
Anciens postes connus de Steve Krognes
| Sociétés | Poste | Fin |
|---|---|---|
| GRITSTONE BIO, INC. | Directeur/Membre du Conseil | 17/06/2024 |
| RLS GLOBAL AB (PUBL) | Directeur/Membre du Conseil | 01/01/2023 |
| CORVUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 15/06/2021 |
The California Academy of Sciences
 The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Directeur/Membre du Conseil | 01/01/2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Financier/CFO | 01/09/2015 |
Formation de Steve Krognes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Guardant Health, Inc.
 Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
Danske Bank A/S
 Danske Bank A/S Major BanksFinance Provides banking services | Finance |
The California Academy of Sciences
The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Commercial Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
RLS Global AB
 RLS Global AB BiotechnologyHealth Technology Develops biochemical products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Genentech Access To Care Foundation |
